-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ems-911-workforce-disposition-comments.pdf
November 01, 2022 - workforce-infection-control/report
Published Online: November 1, 2022
2
Summary of Peer Reviewer Comments and Author … 911-workforce-infection-control/report
Published Online: November 1, 2022
3
Public Comments and Author … We have revised the description of the
results that were reported in the study by
Brown et al.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/depression-brain-injury_research-protocol.pdf
December 09, 2009 - evidence table will vary by key question, but the tables will contain some common
elements, such as author … , year of publication, study location (e.g., country, city, state) and time
period, population description … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied
by a description
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
January 01, 2009 - ACE inhibitor use, 34%; ß-blocker use, 40%) Hospitali-zations and survival
Median followup at 1 year … Applicability Summary Table Template
Domain Description of Applicability Evidence for a Key Question … Completed Applicability Summary Table
Domain Description of Applicability Evidence for a Key Question … angiotensin-converting enzyme; NYHA = New York Heart Association
Comparison Strength of Evidence Conclusions With Description … Author
Author
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs4-opioid-stewardship-protocol.pdf
July 01, 2023 - Timing • Systematic reviews published since 2019
• Original studies published since 2016, the year … Information will be organized according to the
review questions, and will include author, year, study … PSP, outcomes,
implementation barriers and facilitators, resources needed for implementation, and description
-
effectivehealthcare-admin.ahrq.gov/products/strategies-integrating-behavioral-health/protocol
December 01, 2024 - We will consider how recent frameworks might be used to help standardize the description of integration … outcomes: BH-related preventive care measures BH screening services Cost outcomes: Cost per patient per year … Contacting Author. … deemed to meet inclusion criteria, data will be abstracted, including elements such as: study design, year
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/conflict-management_research.pdf
May 01, 2013 - updates of NFCOI should be ongoing, that is, as events warrant, but no less
frequently than once a year … • Because SRs may take a year or more to produce, the SR team members should update their financial … The co-author could act as a ‘guarantor.’
Source: Higgins JPT, Green S, eds. … report, except that, in the case of individuals contributing to any such peer
review process, such description … Non-personal interests involving less than £1000 from all sources in the previous
year need not be declared
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-protocol-amendment.pdf
February 05, 2025 - adolescents in the United States, with nearly 20 percent experiencing a
mental health disorder in a given year … extracting descriptive data related to population and general study characteristics
(e.g., first author … Five-year trends in
US children's health and well-being,
2016-2020.
-
effectivehealthcare-admin.ahrq.gov/products/behavioral-health-screening/protocol
February 01, 2025 - adolescents in the United States, with nearly 20 percent experiencing a mental health disorder in a given year … in extracting descriptive data related to population and general study characteristics (e.g., first author … Five-year trends in US children's health and well-being, 2016-2020.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/autism-update_research-protocol.pdf
September 20, 2013 - participant characteristics (age, diagnosis, symptom severity, etc.), intervention characteristics
(description … evidence table may vary by KQ as appropriate, but the tables will
contain some common elements, such as author … , year of publication, study location (e.g.,
country, city, state) and time period, population description … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008
Principal Investigators … Autism after adolescence: population-based 13- to 22-
year follow-up study of 120 individuals with autism
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_disposition-comments.pdf
October 27, 2015 - biomarkers, enhanced
cystoscopy, and intravesical therapy
efficacy) are well presented with adequate
description … COI - I
was an investigator and co-author of the
trial and I am hard pressed to understand
why the … vs. 3 year
The Oddens trial was
included in our review; as
described in the Results we
believe … Suggest deleting this
retaining the description as a flat high
grade cancer confined to the inside … Need to include study by Rentsch, et al
(Thallman senior author) published this
year comparing induction
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/health-careassociated-infections_disposition-comments.pdf
November 30, 2012 - These details are noted in the
description of each study.
17 Peer Reviewer
#3
General
Comments … The following sentence was added to the Analytic
Framework description: “For example, institutions … Provide a brief description of the search strategy used to
identify relevant QI studies in the nursing … There is a very detailed
description of the literature review process and it seems logical
and comprehensive
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-protocol.pdf
October 01, 2023 - adolescents in the United States, with nearly 20 percent experiencing a
mental health disorder in a given year … extracting descriptive data related to population and general study characteristics
(e.g., first author … Five-year trends in
US children's health and well-being,
2016-2020.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_disposition-comments.pdf
May 08, 2013 - This wide range reflects the
huge diversity in the prevalence studies with respect to the
location, year … This helps to avoid misinterpretation
and to ensure that the reader is aware of the year in which the … "high-
risk" patients based on cardiovascular risk prediction
instruments have a 10-year risk of only … We
found no studies by Cherry that met inclusion criteria; most of
the studies by this author addressed … management of venous
stasis ulcers (not prevention of pressure ulcers) and one
article by this author
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ear-infection_research-protocol.pdf
August 07, 2012 - occurring childhood illnesses in the United States with more than
2.2 million diagnosed cases each year … Original Protocol Revised Protocol Rationale
7/30/2012 II In the Picots table; in the
comparator description … In the Picots table; in
the comparator
description box:
“Different
combinations of the
above interventions … the comparator
comparator description
description box:
box: “Different
“Different
combinations of … be
considered as
appropriate
comparators for oral
or nasal steroids only”
added to comparator
description
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/worker-health_research-protocol.pdf
May 26, 2015 - will abstract data into categories that include
(but are not limited to) the following: study design, year
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/c-diff-infections_disposition-comments.pdf
March 01, 2012 - pre-existing
conditions documented, are all identical to
those reported in another study by the same
author … We reworded the sample description to clarify
that all subjects had recurrent CDI. … We reworded the sample description to clarify
that all subjects had recurrent CDI
Peer Reviewer
#4 … PCP office in a flowchart method – IF patient presents with
weight loss AND had surgery in the past year … Description of studies evaluating risk
factors for Clostridium difficile associated diarrhea
(CDAD)
-
effectivehealthcare-admin.ahrq.gov/products/colorectal-surgery-preparation/research-protocol
December 01, 2019 - Please see the preceding section for a detailed description of the populations, interventions, and outcomes … We will not restrict searches by year of publication. … Author contact will be by email (to the corresponding author of each study), with a primary contact attempt … those with mixed populations); subgroup analyses (e.g., separately by anatomic site of surgery, or by year … In the event of protocol amendments, the date of each amendment will be accompanied by a description
-
effectivehealthcare-admin.ahrq.gov/products/abnormal-uterine-bleeding/research-protocol
December 01, 2020 - PICOTS Criteria
PICOTS Element
Description
1 Surgical interventions and procedures … (See Appendix B for the alternate text description.)
Figure 1. … We will review these studies for evaluable data from patients meeting the description of the population … The evidence tables will contain common elements such as author, year of publication, study location … (e.g., city, state), enrollment period, population description, sample size, and study type (e.g., RCT
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-disposition-comments.pdf
May 22, 2023 - AHRQEPCCER260
https://effectivehealthcare.ahrq.gov/products/search
Summary of Peer Reviewer Comments and Author … products/improved-cancer-outcomes/research
Published Online: May 22, 2023
3
Public Comments and Author … Question (e.g., a-d) appear to have been almost
entirely ignored in this report, outside of their
description
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
April 20, 2015 - resected tumors.[1, 3] It is known that
kidney cancer affects approximately 65,000 new patients each year … stage T1N0M0, ≤ 7 cm in
diameter; stage T2N0M0, > 7 cm in diameter) have excellent outcomes with 5-year … All
extirpative options are associated with an excellent oncologic cure rate (> 95% 5-year disease … exclude studies that:
do not report the health outcomes of
interest
OR
do not give an adequate description … more
Every other uncontrolled study will
get listed in the appendix with the
following data:
Author